Related Experiment Video
Updated: Mar 12, 2026

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
Published on: June 13, 2018
Tumor-induced Osteomalacia in a 3-Year-Old With Unresectable Central Giant Cell Lesions
Stephanie S Crossen1, Eduardo Zambrano, Beverley Newman
1Divisions of *Pediatric Endocrinology and Diabetes §Medical Genetics ¶Pediatric Hematology and Oncology Departments of †Pathology ‡Radiology ∥Otolaryngology, Stanford University School of Medicine, Stanford, CA.
Abstract:
Tumor-induced osteomalacia (TIO) is a rare cause of hypophosphatemia involving overproduction of fibroblast growth factor 23. TIO has been described largely in adults with small mesenchymal tumors. We report a case of TIO in a child who presented with knee pain and radiographic findings concerning for rickets, and was found to have maxillomandibular giant cell lesions. The patient was treated with oral phosphorus and calcitriol, surgical debulking, and intralesional corticosteroids, which resulted in tumor regression and normalization of serum fibroblast growth factor 23 and phosphorus. This case illustrates the occurrence of this rare paraneoplastic syndrome in children and adds to our knowledge about clinical manifestations and pathologic findings associated with pediatric TIO.

